Super-response to renal denervation in treatment-resistant essential hypertension.
Nawaz Z SafdarMuhammad Usman ShahAli AliSyed Yaseen NaqviPublished in: BMJ case reports (2024)
Renal denervation may be indicated in patients with treatment-resistant essential hypertension to decrease sympathetic nervous activity and optimise blood pressure. We present the case of a woman in her 50s with long-standing essential hypertension, a previous transient ischaemic attack, obesity and a family history of cardiovascular disease, who presented with persistent 24-hour ambulatory hypertension despite ongoing lifestyle modifications and being on five antihypertensive agents with no evidence of an alternative primary aetiology. She had intermittent palpitations and blurring of vision alongside evidence of left ventricular hypertrophy on a CT scan. She underwent renal denervation, following which, not only was she able to cease all antihypertensive therapy but managed to maintain optimised blood pressure with subsequent reversal of left ventricular hypertrophy. Trials have demonstrated modest but inconsistent reductions in blood pressure whereas our case represents a 'super-response' likely due to a higher number of circumferential ablations in comparison to previous studies.
Keyphrases
- blood pressure
- hypertensive patients
- left ventricular
- cardiovascular disease
- heart rate
- metabolic syndrome
- computed tomography
- heart failure
- type diabetes
- weight loss
- acute myocardial infarction
- blood glucose
- magnetic resonance imaging
- mitral valve
- hypertrophic cardiomyopathy
- physical activity
- stem cells
- magnetic resonance
- weight gain
- left atrial
- case report
- dual energy
- high intensity
- atrial fibrillation
- positron emission tomography
- adipose tissue
- blood brain barrier
- image quality
- smoking cessation
- cerebral ischemia
- cardiovascular events
- contrast enhanced
- replacement therapy
- bone marrow
- pet ct
- cell therapy
- glycemic control